Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 479

1.

Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.

Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.

Clin Sci (Lond). 2008 Jul;115(1):25-33.

PMID:
18088236
2.

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.

Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL.

J Am Coll Cardiol. 2003 Feb 5;41(3):360-70.

3.

High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.

Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.

Clin Chim Acta. 2009 Aug;406(1-2):113-8. doi: 10.1016/j.cca.2009.06.005. Epub 2009 Jun 10.

PMID:
19523463
4.

High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.

Ames PR, Matsuura E, Batuca JR, Ciampa A, Lopez LL, Ferrara F, Iannaccone L, Alves JD.

Lupus. 2010 May;19(6):711-6. doi: 10.1177/0961203309357765. Epub 2010 Jan 11.

PMID:
20064910
5.

Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.

Vuilleumier N, Bas S, Pagano S, Montecucco F, Guerne PA, Finckh A, Lovis C, Mach F, Hochstrasser D, Roux-Lombard P, Gabay C.

Arthritis Rheum. 2010 Sep;62(9):2640-50. doi: 10.1002/art.27546.

6.
7.

IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.

Cojocaru IM, Cojocaru M, Burcin C.

Rom J Intern Med. 2006;44(2):165-70.

PMID:
17236297
8.

Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease.

Soltesz P, Veres K, Laczik R, Der H, Csipo I, Timar O, Szomjak E, Szegedi G, Szodoray P.

Thromb Haemost. 2007 Aug;98(2):413-9.

PMID:
17721625
10.

Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.

Batuca JR, Ames PR, Amaral M, Favas C, Isenberg DA, Delgado Alves J.

Rheumatology (Oxford). 2009 Jan;48(1):26-31. doi: 10.1093/rheumatology/ken397. Epub 2008 Nov 10.

PMID:
19000993
11.

Antibodies against oxLDL and acute coronary syndrome.

Medeiros AM, von Mühlen CA, Gidlund MA, Bodanese R, Gottlieb MG, Bodanese LC.

Arq Bras Cardiol. 2010 Jul;95(1):47-54. Epub 2010 Jun 11.

12.

Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.

Zhao D, Ogawa H, Wang X, Cameron GS, Baty DE, Dlott JS, Triplett DA.

Am J Clin Pathol. 2001 Nov;116(5):760-7.

PMID:
11710695
13.

Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease.

Vuilleumier N, Reber G, James R, Burger D, de Moerloose P, Dayer JM, Roux-Lombard P.

J Autoimmun. 2004 Dec;23(4):353-60.

PMID:
15571929
14.

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.

Tsimikas S, Brilakis ES, Lennon RJ, Miller ER, Witztum JL, McConnell JP, Kornman KS, Berger PB.

J Lipid Res. 2007 Feb;48(2):425-33. Epub 2006 Nov 8.

15.
17.

Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.

Vuilleumier N, Rossier MF, Pagano S, Python M, Charbonney E, Nkoulou R, James R, Reber G, Mach F, Roux-Lombard P.

Eur Heart J. 2010 Apr;31(7):815-23. doi: 10.1093/eurheartj/ehq055. Epub 2010 Feb 22.

PMID:
20176799
18.

Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome.

Laczik R, Szodoray P, Veres K, Szomják E, Csípo I, Sipka S Jr, Shoenfeld Y, Szekanecz Z, Soltész P.

Lupus. 2011 Jun;20(7):730-5. doi: 10.1177/0961203311398884. Epub 2011 Apr 19.

PMID:
21505011
19.

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.

Vuilleumier N, Bratt J, Alizadeh R, Jogestrand T, Hafström I, Frostegård J.

Scand J Rheumatol. 2010 Nov;39(6):447-53. doi: 10.3109/03009741003742755. Epub 2010 Jul 6.

PMID:
20604674
20.

Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.

O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A.

Arthritis Rheum. 2010 Mar;62(3):845-54. doi: 10.1002/art.27286.

Supplemental Content

Support Center